Universal Ibogaine (TSXV:IBO) Dividend Payout Ratio : 0.00 (As of Jan. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Universal Ibogaine Dividend Payout Ratio?

Universal Ibogaine's dividend payout ratio for the months ended in Jan. 2024 was 0.00.

The historical rank and industry rank for Universal Ibogaine's Dividend Payout Ratio or its related term are showing as below:

TSXV:IBO's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.44
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-06-25), the Dividend Yield % of Universal Ibogaine is 0.00%.

Universal Ibogaine's Dividends per Share for the months ended in Jan. 2024 was C$0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Universal Ibogaine Dividend Payout Ratio Historical Data

The historical data trend for Universal Ibogaine's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Universal Ibogaine Dividend Payout Ratio Chart

Universal Ibogaine Annual Data

Trend

Mar17

Mar18

Mar19

Mar20

Mar21

Jul22

Jul23

Dividend Payout Ratio

Get a 7-Day Free Trial

Universal Ibogaine Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Universal Ibogaine's Dividend Payout Ratio

For the Biotechnology subindustry, Universal Ibogaine's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Universal Ibogaine's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Universal Ibogaine's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Universal Ibogaine's Dividend Payout Ratio falls into.

Universal Ibogaine Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Universal Ibogaine's Dividend Payout Ratio for the fiscal year that ended in Jul. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Jul. 2023 )	/	EPS without NRI (A: Jul. 2023 )
	=	0	/	-0.009
	=	N/A

Universal Ibogaine's Dividend Payout Ratio for the quarter that ended in Jan. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jan. 2024 )	/	EPS without NRI (Q: Jan. 2024 )
	=	0	/	-0.001
	=	N/A

Universal Ibogaine (TSXV:IBO) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Universal Ibogaine Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Universal Ibogaine's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Universal Ibogaine (TSXV:IBO) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Universal Ibogaine Inc (TSXV:IBO) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

IBOGF:USA JC4:Germany

Address

400 3rd Avenue South west, Suite 1470, Calgary, AB, CAN, T2P 4H2

Website

https://www.universalibogaine.com

Universal Ibogaine Inc develops a platform of addiction treatment clinics, which use ibogaine as a primary modality for the interruption and ideally cessation of addictions to primarily opioids such as oxycodone, heroin, fentanyl, as well as alcohol, cocaine, and other stimulants. It runs addiction clinics it has a research partner clinic in Mexico.

Executives

Ian Rabb

Senior Officer

Universal Ibogaine (TSXV:IBO) Headlines

No Headlines